| Apr'19 | Apr'18 | Apr'17 | Apr'16 | Apr'15 | Apr'14 | Apr'13 |
|---|---|---|---|---|---|---|
Net sales | ||||||
30,557 | 29,953 | 29,710 | 28,833 | 20,261 | 17,005 | 16,590 |
Costs and expenses: | ||||||
Cost of products sold | ||||||
9,155 | 9,067 | 9,294 | 9,142 | 6,309 | 4,333 | 4,126 |
Research and development expense | ||||||
2,330 | 2,256 | 2,193 | 2,224 | 1,640 | 1,477 | 1,557 |
Selling, general, and administrative expense | ||||||
10,418 | 10,238 | 10,018 | 9,469 | 6,904 | 5,847 | 5,698 |
Amortization of intangible assets | ||||||
1,764 | 1,823 | 1,980 | 1,931 | 733 | 349 | 331 |
Special (gains) charges, net | ||||||
- | - | - | - | - | - | 0 |
Restructuring charges, net | ||||||
198 | 30 | 303 | 290 | 237 | 78 | 172 |
Acquisition-related items | ||||||
- | - | - | 283 | 550 | 117 | -49 |
Certain litigation charges | ||||||
166 | 61 | 300 | 26 | 42 | 770 | 245 |
Divestiture-related items | ||||||
- | - | - | 0 | - | - | - |
Gain on sale of businesses | ||||||
0 | 697 | 0 | 0 | - | - | - |
Other operating (income) expense, net | ||||||
-258 | -535 | -239 | - | - | - | - |
Special charge | ||||||
- | - | - | 0 | -38 | 40 | - |
Other expense, net | ||||||
- | - | - | -107 | -118 | -181 | -108 |
Operating profit (loss) | ||||||
6,268 | 6,640 | 5,383 | 5,361 | 3,766 | 3,813 | 4,402 |
Other non-operating income, net | ||||||
373 | 181 | 313 | - | - | - | - |
Investment loss | ||||||
- | - | - | 70 | - | - | - |
Interest income | ||||||
- | - | - | 431 | 386 | 271 | 237 |
Interest expense | ||||||
1,444 | 1,146 | 1,094 | 1,386 | 666 | 379 | 388 |
Interest expense, net | ||||||
- | - | - | -955 | -280 | -108 | -151 |
Income (loss) before income taxes | ||||||
5,197 | 5,675 | 4,602 | 4,336 | 3,486 | 3,705 | 4,251 |
Income tax provision | ||||||
547 | 2,580 | 578 | 798 | 811 | 640 | 784 |
Net income (loss) | ||||||
4,650 | 3,095 | 4,024 | 3,538 | 2,675 | - | - |
Net income attributable to noncontrolling interests | ||||||
19 | -9 | -4 | 0 | 0 | - | - |
Net income (loss) attributable to Medtronic | ||||||
4,631 | 3,104 | 4,028 | 3,538 | 2,675 | 3,065 | 3,467 |
Basic earnings per share (usd per share) | ||||||
3.44 | 2.29 | 2.92 | 2.51 | 2.44 | 3.06 | 3.40 |
Diluted earnings per share (usd per share) | ||||||
3.41 | 2.27 | 2.89 | 2.48 | 2.41 | 3.02 | 3.37 |
Basic weighted average shares outstanding (shares) | ||||||
1,346 | 1,356 | 1,378 | 1,409 | 1,095 | 1,002 | 1,019 |
Diluted weighted average shares outstanding (shares) | ||||||
1,357 | 1,368 | 1,391 | 1,425 | 1,109 | 1,013 | 1,027 |
Cash dividends declared per ordinary share (usd per share) | ||||||
- | - | - | 1.52 | 1.22 | 1.12 | 1.04 |